Skip to main content

High-touch surfaces: microbial neighbours at hand


Despite considerable efforts, healthcare-associated infections (HAIs) continue to be globally responsible for serious morbidity, increased costs and prolonged length of stay. Among potentially preventable sources of microbial pathogens causing HAIs, patient care items and environmental surfaces frequently touched play an important role in the chain of transmission. Microorganisms contaminating such high-touch surfaces include Gram-positive and Gram-negative bacteria, viruses, yeasts and parasites, with improved cleaning and disinfection effectively decreasing the rate of HAIs. Manual and automated surface cleaning strategies used in the control of infectious outbreaks are discussed and current trends concerning the prevention of contamination by the use of antimicrobial surfaces are taken into consideration in this manuscript.


In spite of the growing global commitment towards an effective reduction of healthcare-associated infections (HAIs), it is unfortunately certain that such infections will continue to be responsible for very high morbidity, increased costs and length of stay (LOS) for the coming decades [1, 2].

Among potential sources of pathogens causing HAIs, the most frequent are the patient’s microbiota and the hands of healthcare personnel [3]. Additionally, evidence that high-touch surfaces (HTS) will work as an extra source of microbial pathogens accumulated over the years, e.g., several microorganisms can survive on medical equipment for hours to months, improved cleaning and disinfection of surfaces decrease the rate of HAI, and hospital environmental screening results and the study of clonal outbreaks, all have given support to the role of contaminated HTS in the transmission of pathogens between patients and healthcare personnel [4]. From surfaces, microbial transmission may occur either through direct patient contact or, indirectly, through healthcare personnel hands or gloves [5]. Therefore, upon potentially preventable sources of microorganisms, contaminated HTS deserve strong consideration.

Microbial pathogens most frequently involved in the contamination of hospital environmental surfaces are (methicillin-resistant) Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), Clostridium difficile, multidrug resistant Gramme-negative bacilli (such as Pseudomonas, Acinetobacter and Enterobacteriaceae), Norovirus, Coronavirus and Candida species [6,7,8,9,10].

Strategies for cleaning contaminated HTS may include manual and automated techniques. Wipes and cloths with application of detergents or disinfectants are examples of manual techniques, while automated methods may involve UV light, hydrogen peroxide, steam vapour, ozone and HINS (high-intensity narrow-spectrum light). On the other side, in order to prevent contamination of HTS, antimicrobial surfaces are being developed. The inhibition of microbial adhesion with repellent films is a possible strategy, as it is the surface treatment with antimicrobial coatings of silver, copper, polycations, triclosan, bacteriophages or, even, light-activated biotoxic radicals.

The aim of this manuscript is to review the role of high-touch surfaces in healthcare-associated infections, from the aetiology to strategies for surface cleaning and addressing preventive trends.

Types of surfaces

As early as 1972, Spaulding proposed a classification of inanimate surfaces into three general categories based on the risk of infection if the surfaces were contaminated at the time of use [11]. These categories can be applied to devices or instruments as follows: critical (exposed to normally sterile areas of the body; require sterilization), semi-critical (touch mucous membranes; may be sterilized or disinfected), and non-critical (touch skin or come into contact with people only indirectly; can be either cleaned and then disinfected with an intermediate-level disinfectant, sanitized with a low-level disinfectant or, simply, cleaned with water and soap). In 1991, the CDC proposed environmental surfaces (floors, walls and other “housekeeping surfaces” that do not make direct contact with a person’s skin) as an additional category [12]. More recently, the CDC’s and Healthcare Infection Control Practices Advisory Committee’s Guidelines for Environmental Infection Control in Healthcare Facilities [13] divided surfaces into patient care items and environmental surfaces. Environmental surfaces were further divided into medical equipment and patient room surfaces (Table 1).

Table 1 Types of healthcare-associated surfaces

Over the years, research has been done in order to better target room disinfection practices. Following recommendations made by the CDC to clean and disinfect HTS more frequently than minimal-touch surfaces, data published in 2010 by Huslage et al., based on the real frequency of contact, defined the top five most touched surfaces in hospitals: bed rails, bed surface, supply cart, over-bed table and intravenous pump [14]. HTS may be classified as non-critical items (the contact occurs with intact skin that effectively acts as a barrier to most pathogens, but not with mucous membranes) and must be subject to cleaning and disinfection procedures as recommended, but with no absolute need for sterilization [15].

Microbial pathogens

Many pathogens may thrive on healthcare-associated equipment and environmental surfaces. Among such organisms, MRSA, VRE, C. difficile, P. aeruginosa, A. baumannii, Enterobacteriaceae, Stenotrophomonas maltophilia, Burkholderia cepacia, Norovirus, Coronavirus and Candida spp. may persist and contribute to the infection risk to which patients are systematically exposed.

Methicillin-resistant Staphylococcus aureus

Several studies have demonstrated that basic cleaning leads to MRSA elimination from environmental surfaces and enhanced cleaning may terminate outbreaks in intensive care units, with cost savings of $45,000 up to $51,000 per year [16,17,18,19]. Recently, two studies reported positively about pulsed xenon UV and hydrogen peroxide methods to boost the decontamination of patient rooms, contributing towards a reduction of MRSA bioburden [20, 21].

Vancomycin-resistant enterococci

Its inherent ability to resist certain antimicrobial agents (such as cephalosporins and aminoglycosides) allied to a great capacity to acquire determinants of antibiotic resistance (like gene clusters of vancomycin resistance) turn enterococci into a versatile nosocomial multidrug-resistant pathogen. The number of VRE infections has been increasing worldwide, most frequently afflicting patients with serious comorbidities or undergoing prolonged hospitalization [22].

VRE are known to survive for a long time in the hospital environment. Viability on surfaces may range from 5 days to 4 months [23]. Moreover, enterococci are tolerant to heat, chlorine and some alcohol preparations, making them very resilient to conventional cleaning practices, thus becoming easily disseminated among healthcare facilities [24]. Therefore, besides thorough environmental cleaning several times a day with disinfectants, VRE management protocols should include strict adoption of contact precautions and implementation of comprehensive educational programs for staff [25, 26].

Clostridium difficile

Spores of C. difficile can hold on to a healthcare environment for more than 5 months [23, 27]. Fortunately, the use of chlorine-releasing disinfectants reduces the amount of spores in the environment, with some evidence suggesting that it may reduce the risk of recurrence and transmission of C. difficile-associated infections [28].

Pseudomonas aeruginosa

Transmission of P. aeruginosa may easily occur from contaminated sinks to hands of healthcare personnel during washing, since this organism may thrive in biofilms that are adherent to sink traps, pipes, water lines and hospital drains [29], turning these fashion-organized bacteria more prone to resist to disinfectants [30]. Additionally, P. aeruginosa can resist 6 hours to 16 months on dry inanimate surfaces [23]. Programs to control transmission should include, therefore, repeated cleaning with chlorine-based disinfectants, physical removal of persistent biofilm, replacement of components whenever feasible and regular inspection [31, 32].

Acinetobacter baumannii

The increase in the number of HAIs caused by A. baumannii might be explained not only by its ability to persist from 5 days to more than 5 months in undisturbed surfaces of healthcare equipment [23], but also by its high resilience to cleaning with conventional detergent and alcohol disinfectants [33]. Hence, outbreaks in hospital or other healthcare settings are difficult to contain because of the easy environmental contamination by this pathogen [34,35,36]. Targeted infection control measures may be needed, including intensive cleaning with sodium hypochlorite and subsequent measurement of cleanliness, hand hygiene training, adoption of barrier precautions and contact isolation, as well as patient surveillance [37, 38].


There has been a growing concern about Klebsiella pneumoniae infections, mainly because of its extensive β-lactamase resistance. K. pneumoniae are usual colonizers of the human gastrointestinal tract, pharynx and skin that may cause wound infections, pneumonia and sepsis, particularly in immunocompromised patients [39]. More recently, given its wide dissemination and selective advantage to resist to carbapenem antibiotics, K. pneumoniae have been showing a propensity to cause outbreaks in healthcare institutions [40]. It is known that K. pneumoniae may survive for more than 30 months in the healthcare environment [23] and that the origin of some outbreaks has been related to sinks and related pipes [41, 42].

Another member of the Enterobacteriaceae family, Serratia marcescens, are known to cause pneumonia, meningitis, urinary tract and bloodstream infections. MDR isolates, including colistin resistant [43], have been responsible for serious outbreaks among intensive care units and critically ill neonates [44,45,46]. S. marcescens are known to survive up to 2 months on dry inanimate surfaces [23] and have frequently been recovered from water pipes and hospital disinfectants [47].

Because of the easy transmission and environmental persistence of Enterobacteriaceae in healthcare facilities, adequate solutions aiming its eradication should ensure comprehensive educational interventions, hand hygiene training, chlorine-based cleaning and even the replacement of sinks and pipes [42, 48, 49].

Stenotrophomonas maltophilia

Similarly to other bacteria, it can persist in biofilms that may turn cleaning products and disinfectants more ineffective [30]. Long-term control of S. maltophilia will be dependent upon the integration of an efficient cleaning strategy into a targeted healthcare facilities maintenance program [50].

Burkholderia cepacia

It is widely distributed in soil and water habitats and recent healthcare-associated outbreaks have been linked to B. cepacia persistence in disinfectants, drugs, medical devices (e.g., respiratory nebulizers), sinks and contiguous aerator filters [51,52,53]. Strict and repeated cleaning and replacement of aerators with flow straighteners may be required to stop outbreaks [51, 54].


The origin of Norovirus outbreaks in healthcare facilities has been traced not only to sites near bathroom showers and toilets but also to sites near patients, including clinical equipment (e.g., blood pressure and pulse oximeter monitors), thermometers, trolleys and soap and alcohol gel containers [55]. After suspected or confirmed case contact, use of soap and running water is recommended [56], probably with a superior efficacy than ethanol-based sanitizers [57]. However, detergent-based cleaning may be insufficient to eliminate Norovirus from the environment and, therefore, hypochlorite solutions of at least 1000 ppm for an appropriate contact time represent a better strategy for cleaning [56, 58].


Human Coronavirus, usually responsible for acute respiratory syndromes, have been causing increased concern due to contact transmission during healthcare-associated outbreaks. Viral persistence on doorknobs and surgical boom shelves has already been identified, with a presumed viability of 48 h; scrupulous environmental cleaning is certainly highly advisable in reducing the spread [59, 60]. Moreover, biocidal surfaces based on copper alloys are very effective in inactivating Coronavirus and could be employed in high touch surfaces in order to prevent the transmission of this respiratory virus [61].


Although Candida spp. are more resistant to germicidal chemicals than most vegetative bacteria, there are no specific recommendations other than general healthcare surface decontamination with disinfectants. Nevertheless, in order to control a recent outbreak by a MDR C. auris, measures implemented included isolation of cases and contacts, protective clothing, screening of all other ward patients, skin decontamination with chlorhexidine, environmental cleaning with chlorine-based disinfectants and hydrogen peroxide vapour [62]. A clinical alert issued in June 2016 by the CDC on the global emergence of invasive infections caused by the MDR C. auris recommended thorough daily and terminal cleaning and disinfection of patient rooms using an EPA-registered hospital grade disinfectant with a fungal claim.

Preventing the environmental surface transmission of healthcare-associated pathogens

General strategies

Based on patterns of microbial resistance to physical and chemical germicidal agents and on the instrument/surface classification, Spaulding has proposed three levels of disinfection [11]: high-level disinfection, that inactivates all vegetative bacteria, mycobacteria, viruses, fungi and some bacterial spores by the action of chemicals such as glutaraldehyde, peracetic acid and hydrogen peroxide; intermediate-level disinfection, which is effective against vegetative bacteria, some spores, mycobacteria, fungi, lipid and medium size viruses, but not against all nonlipid and small size viruses (e.g., sodium hypochlorite, alcohols, some phenolics and some iodophors); and low-level disinfection, that inactivates vegetative bacteria, fungi, enveloped viruses and some non-enveloped viruses (e.g., adenoviruses) by the action of quaternary ammonium compounds, some phenolics and some iodophors [12].

In order to prevent the persistence of microbial pathogens on medical equipment and environmental surfaces, education of healthcare staff, checklists and assessment of the adequacy of cleaning (by direct observation, use of fluorescent markers, of ATP bioluminescence systems, swab cultures or agar slide cultures) with feedback to the staff are general interventions that need to be implemented to improve the frequency of adequate cleaning [63,64,65].

Strategies for high-touch surfaces

Patient care items

As general principles, all patient care items should be cleaned and/or decontaminated before and after use, for all patients [66, 67]; whenever these items come into contact with blood or other body fluids, stringent cleaning and disinfection is warranted before and after use [68].

Manufacturers of medical equipment usually provide care and maintenance instructions regarding servicing decontamination, compatibility with germicidal agents and water-resistance. In the absence of such instructions, the CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC) recommend non-critical medical equipment (e.g., stethoscopes, blood pressure cuffs, equipment knobs and controls) to be subject to low or intermediate-level disinfection after cleansing, depending on the nature and degree of contamination. For instance, ethyl or isopropyl alcohol (60–90% v/v) may be used to disinfect small surfaces (e.g., rubber stoppers of multiple-dose medication vials and thermometers) and surfaces of healthcare equipment (e.g., stethoscopes and ventilators) [69], while for large surfaces it may be impractical due to the rapid evaporation of alcohol and absence of the adequate contact time [12].

Environmental surfaces

As a whole, frequently touched environmental surfaces benefit from enhanced cleaning. Routine decontamination and disinfection are practices normally included within institutional cleaning policies. Nevertheless, evidence has been built in order to favour the use of less toxic detergents over disinfectants in non-outbreak situations, without losing cleaning efficacy or adding costs [70]. Detergents are less likely to contribute to the accumulation or dispersal of tolerance or resistance genes among healthcare-associated microbial isolates [71, 72].

According to the CDC, for medical equipment (particularly in the case of monitor touch screens, controls and cables), a disposable plastic barrier protection can be useful whenever these surfaces, touched frequently by gloved hands, may become contaminated with body fluids or present difficulties to cleaning.

Manual cleaning

The physical removal of soil is a very important step in the cleaning process since its presence will impede the microbicidal activity of disinfectants, if needed. In order to control the bioburden on regular wards, daily cleaning with neutral detergent wipes is usually sufficient. However, more attention is essential on high-risk intensive care units because of the easiness of microbial recontamination [73]. Moreover, patients colonized or infected with specific pathogens may demand cleaning regimens with disinfectants with registered label claims [68].

After patient discharge, terminal or deep cleaning is usually performed by removal of all detachable objects from the room and systematically wiping all surfaces downward to the floor level, with detergent cloths or disinfectant wipes.

New liquid disinfectants are under development and include: improved hydrogen peroxide disinfectants, effective in reducing bacterial levels on surfaces [74, 75], related to fewer HAIs [76] and able to reduce contamination by MDR pathogens on soft surfaces such as bedside curtains [77]; peracetic acid and hydrogen peroxide disinfectants, a sporicidal combination that was shown to lower bacterial levels on surfaces and to reduce the contamination by MRSA, VRE and C. difficile as effectively as sodium hypochlorite [78]; electrolyzed water (hypochlorous acid) disinfectant, which may reduce bacterial levels on surfaces near patients in a higher degree than quaternary ammonium disinfectants [79]; further promising, electrolyzed water has been sprayed onto medical equipment (with a short contact time and without the need for wiping because no toxic residue remains on surfaces) with a reduction of aerobic bacteria and C. difficile spores [80]; cold-air atmospheric pressure plasma systems, which generate reactive oxygen species (ROS) with bactericidal activity and have potential use as surface disinfectants [81, 82]; nebulized polymeric guanidine, under investigation for its antimicrobial activity against several healthcare-associated pathogens [83].

Together with disinfectants, novel materials for liquid application such as microfiber cloths or mops and ultramicrofiber cloths are under development. When used according to manufacturers’ instructions, an increased cleaning efficacy is to be expected as compared to standard cotton cloths or mops [84].

Automated cleaning

On the pathway to improve quality and ease of cleaning environmental surfaces, considerable efforts have been dedicated towards the development of automated devices. However, because of yet unsolved safety risks, mainly for patients, automated solutions are invariably targeting terminal cleaning. In most instances, these solutions do not preclude preliminary manual cleaning of surfaces to remove residual debris and reduce the bioburden.

The microbicidal effect of UV light has been in use for disinfection of environmental surfaces, instruments and air. By damaging the molecular bonds in DNA, a reduction in contamination by MRSA, VRE and C. difficile on high-touch surfaces has been achieved [85]. Automated mobile UV light devices are easy to use, with minimal need for special staff training. Nonetheless, several issues have been raised that may hinder its efficacy, namely, the time and intensity of light exposure and potential barriers that may exist between the lamp and its target surface. As such, UV light is regarded as an effective adjunct, but not a stand-alone strategy for disinfection [86].

By producing free radicals that lead to oxidation of DNA, proteins and membrane lipids [87], vapour and aerosol hydrogen peroxide systems have already been shown to be effective against MRSA, VRE, MDR Gramme-negative bacilli, C. difficile, viruses and fungi [88,89,90,91,92,93]. This excellent wide spectrum antimicrobial activity is not without drawbacks, such as toxicity after accidental exposure, minor erosion of environmental polymers and damage of electronic equipment. In addition, there is the need for trained operators, long cycle times for disinfection and the cost is high [94]. Experiments suggest that vapour-phase hydrogen peroxide is a more potent oxidizer of protein than liquid-phase hydrogen peroxide [87] and, when supplementing other strategies, micro-condensation hydrogen peroxide vapour systems may have contributed to control outbreaks by MRSA, MDR Gramme-negative bacteria and C. difficile in intensive care units, surgical wards and long-term care facilities [89, 95,96,97,98,99]. A novel silver-stabilized hydrogen peroxide is under investigation for its enhanced biocidal activity towards Gramme positive and negative bacteria capable of producing catalase, both in planktonic and biofilm cultures. Silver probably helps to stabilize and target hydrogen peroxide to the bacterial cell surface acting, therefore, synergistically [100]. In fact, a previous report on the effect of a dry-mist system using a mixture of hydrogen peroxide (5%) and silver cations (<50 ppm) was effective in decontaminating burn patient rooms, as well as a fungal research laboratory: a reduction in growth of at least two log was observed for tested bacteria, mycobacteria and fungi [101].

Steam cleaning is a non-toxic and rapid method that may reduce the total bioburden from environmental surfaces by more than 90% [102], with effectiveness against MRSA, VRE and Gramme-negative bacilli [103]. Concerns about security when steam is applied to electrical items such as switches and buttons and risk of burns and scalds when cleaning a crowded ward are the reasons precluding its widespread use in healthcare facilities [104].

The oxidizing capacity of ozone justifies its previous evaluation as a gaseous decontaminant for controlling C. difficile on environmental surfaces and E.coli in hospital laundries [105, 106]. While it seems highly effective against vegetative bacterial cells, a smaller impact has been found in case of bacterial spores and fungi [107]. Moreover, corrosiveness and toxicity issues may restrain further the use of ozone in healthcare settings [108].

By targeting intracellular porphyrins that absorb the light and produce ROS with bactericidal activity [109], high-intensity narrow-spectrum (HINS) light stands as another light-based method with possible application for decontamination of high-touch surfaces, although its efficacy is lower than UV light. As clear advantages, HINS light is safe for patients, allowing continuous decontamination of the clinical environment [110] and it exhibits a wide-range microbicidal activity that includes MRSA, P. aeruginosa and A. baumannii [111, 112]. However, HINS light has yet to prove its effectiveness in clinical settings and benefits upon HAI rates, given the small range of published studies [110, 112, 113].

Antimicrobial surfaces

Instead of focusing on the reduction of the bioburden on surfaces solely by cleaning, there are solutions designed to prevent surfaces from working as a microbial reservoir and that may be used as an adjunct to other strategies in reducing HAIs.

Antiadhesive surfaces target microbial adhesion usually by the interaction of antagonist physicochemical properties. Easy-clean surfaces that are hydrophobic repel bacteria better than glass-coated controls [114], while hydrophilic surfaces favour water sheeting and subsequent cleaning. Similarly, polyethylene glycol coated surfaces promote a hydrophilic interaction against bacteria, preventing attachment [115]. The use of diamond-like carbon films has already been tried for medical implanted devices such as joint prostheses and stents in order to repel microbial adhesion [116]. Despite being non-toxic and appealing, the lack of biocidal properties may turn discouraging a more generalized implementation of such easy-clean technologies.

Currently, there are available antimicrobial coatings that can produce a microbicidal effect and could lead to an effective reduction of high-touch surface bioburden. For instance, inorganic metals have been investigated for a long time and it is known that silver binds with disulphide and sulfhydryl groups present in proteins of microbial cell wall leading to death [117], inhibiting not only environmental contamination but also colonization of medical implanted devices [118, 119]; copper and copper alloys may form reactive oxygen radicals that damage nucleic acid and proteins [117] and have already demonstrated a potent antimicrobial effect when applied to surfaces, reducing the rate of healthcare-associated infections [120, 121]. Polycationic surfaces, such as those coated with polyethyleneimines, hydrophobically attract and kill bacteria by physically damaging the cell wall [122]. Triclosan has been in use for more than 30 years in detergents, soaps and cosmetics. At lower concentrations, it is bacteriostatic by inhibiting an enzyme involved in fatty acid synthesis and, at higher concentrations, it is bactericidal by destabilizing microbial membranes. Compatibilization of triclosan with polymers may extend the duration of its wide-spectrum antimicrobial activity [123] and could prove effective in reducing environmental surface load of pathogens. Bacteriophages applied to surfaces and targeting specific microorganisms have been attempted and mixtures of phages have been further suggested in order to effectively reduce the environmental bioburden. Particularly interesting in healthcare settings is the fact that MDR pathogens keep vulnerable to the lytic action of phages [124, 125]. Light-activated antimicrobial surfaces, such as those coated with titanium dioxide and activated by UV light [126], generate reactive oxygen radicals with nonselective toxicity towards both bacteria and yeasts [127]. Similarly, photosensitized surfaces could reduce the healthcare bioburden without promoting microbial drug resistance mechanisms. Although antimicrobial coatings may seem very promising, especially as an adjunct measure to more traditional and proven cleaning strategies, some concerns keep hindering its wider use in healthcare settings. Robust cost-effectiveness studies are still lacking since reliable information about antimicrobial coatings durability, resistance and possible toxicity is yet somewhat insufficient [50, 68].


Given the high morbidity and costs associated with HAIs, improved strategies are urgently needed to reduce effectively the rate of infection. Certainly, one good step forward would be the blockade of transmission from environmental high-touch surfaces. At the moment, manual and automated techniques for cleaning surfaces exhibit variable success. Concerns over durability, resistance and toxicity may be precluding a much wider application of the novel antimicrobial coatings. Admitting an albeit limited performance of the traditional cleaning methods, the supplementation with newer technology should be indicated. Hence, more randomized controlled trials and cost-effectiveness studies are needed and further investigation on antimicrobial surfaces is welcomed in order to face the challenge imposed by the global advance of antimicrobial drug resistance and the pressure to reduce bed turnover times with shortages in nursing personnel, housekeeping staff and budgets.


  1. 1.

    Magill SS et al (2014) Multistate point-prevalence survey of health care-associated infections. N Engl J Med 370(13):1198–1208

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  2. 2.

    ECDC (2013) Point Prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals. European Centre for Disease Prevention and Control, Stockholm

    Google Scholar 

  3. 3.

    Weinstein RA (1991) Epidemiology and control of nosocomial infections in adult intensive-care units. Am J Med 91:S179–S184

    Article  Google Scholar 

  4. 4.

    Weber DJ, Anderson D, Rutala WA (2013) The role of the surface environment in healthcare-associated infections. Curr Opin Infect Dis 26(4):338–344

    PubMed  Article  Google Scholar 

  5. 5.

    Han JH et al (2015) Cleaning hospital room surfaces to prevent health care-associated infections: a technical brief. Ann Intern Med 163(8):598–607

    PubMed  PubMed Central  Article  Google Scholar 

  6. 6.

    Dancer SJ (2008) Importance of the environment in meticillin-resistant Staphylococcus aureus acquisition: the case for hospital cleaning. Lancet Infect Dis 8(2):101–113

    PubMed  Article  Google Scholar 

  7. 7.

    Martinez JA et al (2003) Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit. Arch Intern Med 163(16):1905–1912

    PubMed  Article  Google Scholar 

  8. 8.

    Tankovic J et al (1994) Characterization of a hospital outbreak of imipenem-resistant Acinetobacter Baumannii by phenotypic and genotypic typing methods. J Clin Microbiol 32(11):2677–2681

    CAS  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Green J et al (1998) The role of environmental contamination with small round structured viruses in a hospital outbreak investigated by reverse-transcriptase polymerase chain reaction assay. J Hosp Infect 39(1):39–45

    CAS  PubMed  Article  Google Scholar 

  10. 10.

    Kaatz GW et al (1988) Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol 127(6):1289–1294

    CAS  PubMed  Article  Google Scholar 

  11. 11.

    Spaulding (1972) Chemical disinfection and antisepsis in the hospital. J Hosp Res 9:5–31

    Google Scholar 

  12. 12.

    Favero M, Bond W (2001) Chemical disinfection of medical and surgical material, in disinfection, sterilization and preservation. S. Block (ed) Lippencott, Williams and Wilkens, Philadelphia, pp 881–917

    Google Scholar 

  13. 13.

    Sehulster L et al (2003) Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the healthcare infection control practices Advisory Committee (HICPAC). MMWR Recomm Rep 52(RR-10):1–42

    PubMed  Google Scholar 

  14. 14.

    Huslage K et al (2010) A quantitative approach to defining “high-touch” surfaces in hospitals. Infect Control Hosp Epidemiol 31(8):850–853

    PubMed  Article  Google Scholar 

  15. 15.

    Rutala W, Weber D, the Healthcare Infection Control Practices Advisory Committee (2008) Guideline for disinfection and sterilization in healthcare facilities. Centers for Disease Control and Prevention

  16. 16.

    Layton MC et al (1993) An outbreak of mupirocin-resistant Staphylococcus aureus on a dermatology ward associated with an environmental reservoir. Infect Control Hosp Epidemiol 14(7):369–375

    CAS  PubMed  Article  Google Scholar 

  17. 17.

    de Lassence A et al (2006) Control and outcome of a large outbreak of colonization and infection with glycopeptide-intermediate Staphylococcus aureus in an intensive care unit. Clin Infect Dis 42(2):170–178

    PubMed  Article  Google Scholar 

  18. 18.

    Rampling A et al (2001) Evidence that hospital hygiene is important in the control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 49(2):109–116

    CAS  PubMed  Article  Google Scholar 

  19. 19.

    Dancer SJ et al (2009) Measuring the effect of enhanced cleaning in a UK hospital: a prospective cross-over study. BMC Med 7:28

    PubMed  PubMed Central  Article  Google Scholar 

  20. 20.

    Jinadatha C et al (2014) Evaluation of a pulsed-xenon ultraviolet room disinfection device for impact on contamination levels of methicillin-resistant Staphylococcus aureus. BMC Infect Dis 14:187

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  21. 21.

    Mitchell BG et al (2014) Controlling methicillin-resistant Staphylococcus aureus (MRSA) in a hospital and the role of hydrogen peroxide decontamination: an interrupted time series analysis. BMJ Open 4(4):e004522

    PubMed  PubMed Central  Article  Google Scholar 

  22. 22.

    Arias CA, Murray BE (2012) The rise of the enterococcus: beyond vancomycin resistance. Nat Rev Microbiol 10(4):266–278

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  23. 23.

    Kramer A, Schwebke I, Kampf G (2006) How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 6:130

    PubMed  PubMed Central  Article  Google Scholar 

  24. 24.

    Werner G et al (2008) Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill 13(47)

  25. 25.

    Rossini FAF et al (2012) Successful prevention of the transmission of vancomycin-resistant enterococci in a Brazilian public teaching hospital. Rev Soc Bras Med Trop 45(2):184–188

    PubMed  Article  Google Scholar 

  26. 26.

    Yoon YK et al (2009) Epidemiology and control of an outbreak of vancomycin-resistant enterococci in the intensive care units. Yonsei Med J 50(5):637–643

    PubMed  PubMed Central  Article  Google Scholar 

  27. 27.

    Lawley TD et al (2010) Use of purified Clostridium difficile spores to facilitate evaluation of health care disinfection regimens. Appl Environ Microbiol 76(20):6895–6900

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  28. 28.

    Macleod-Glover N, Sadowski C (2010) Efficacy of cleaning products for C. difficile: environmental strategies to reduce the spread of Clostridium Difficile-associated diarrhea in geriatric rehabilitation. Can Fam Physician 56(5):417–423

    PubMed  PubMed Central  Google Scholar 

  29. 29.

    Doring G et al (1996) Distribution and transmission of Pseudomonas Aeruginosa and Burkholderia cepacia in a hospital ward. Pediatr Pulmonol 21(2):90–100

    CAS  PubMed  Article  Google Scholar 

  30. 30.

    Costerton JW et al (1987) Bacterial biofilms in nature and disease. Annu Rev Microbiol 41:435–464

    CAS  PubMed  Article  Google Scholar 

  31. 31.

    Hota S et al (2009) Outbreak of multidrug-resistant Pseudomonas Aeruginosa colonization and infection secondary to imperfect intensive care unit room design. Infect Control Hosp Epidemiol 30(1):25–33

    PubMed  Article  Google Scholar 

  32. 32.

    Kerr KG, Snelling AM (2009) Pseudomonas Aeruginosa: a formidable and ever-present adversary. J Hosp Infect 73(4):338–344

    CAS  PubMed  Article  Google Scholar 

  33. 33.

    Strassle P et al (2012) The effect of terminal cleaning on environmental contamination rates of multidrug-resistant Acinetobacter Baumannii. Am J Infect Control 40(10):1005–1007

    PubMed  Article  Google Scholar 

  34. 34.

    Fournier PE, Richet H (2006) The epidemiology and control of Acinetobacter Baumannii in health care facilities. Clin Infect Dis 42(5):692–699

    PubMed  Article  Google Scholar 

  35. 35.

    Maragakis LL, Perl TM (2008) Acinetobacter Baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 46(8):1254–1263

    CAS  PubMed  Article  Google Scholar 

  36. 36.

    Villegas MV, Hartstein AI (2003) Acinetobacter outbreaks, 1977–2000. Infect Control Hosp Epidemiol 24(4):284–295

    PubMed  Article  Google Scholar 

  37. 37.

    Apisarnthanarak A et al (2008) A multifaceted intervention to reduce pandrug-resistant Acinetobacter Baumannii colonization and infection in 3 intensive care units in a Thai tertiary care center: a 3-year study. Clin Infect Dis 47(6):760–767

    PubMed  Article  Google Scholar 

  38. 38.

    La Forgia C et al (2010) Management of a multidrug-resistant Acinetobacter Baumannii outbreak in an intensive care unit using novel environmental disinfection: a 38-month report. Am J Infect Control 38(4):259–263

    PubMed  Article  Google Scholar 

  39. 39.

    Montgomerie JZ (1979) Epidemiology of Klebsiella and hospital-associated infections. Rev Infect Dis 1(5):736–753

    CAS  PubMed  Article  Google Scholar 

  40. 40.

    Asensio A et al (2000) Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. Clin Infect Dis 30(1):55–60

    CAS  PubMed  Article  Google Scholar 

  41. 41.

    Hobson RP, MacKenzie FM, Gould IM (1996) An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland. J Hosp Infect 33(4):249–262

    CAS  PubMed  Article  Google Scholar 

  42. 42.

    Starlander G, Melhus A (2012) Minor outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in an intensive care unit due to a contaminated sink. J Hosp Infect 82(2):122–124

    CAS  PubMed  Article  Google Scholar 

  43. 43.

    Merkier AK et al (2013) Outbreak of a cluster with epidemic behavior due to Serratia Marcescens after Colistin Administration in a Hospital Setting. J Clin Microbiol 51(7):2295–2302

    PubMed  PubMed Central  Article  Google Scholar 

  44. 44.

    Krawczyk B et al (2003) Evaluation and comparison of random amplification of polymorphic DNA, pulsed-field gel electrophoresis and ADSRRS-fingerprinting for typing Serratia Marcescens outbreaks. FEMS Immunol Med Microbiol 38(3):241–248

    CAS  PubMed  Article  Google Scholar 

  45. 45.

    Villari P et al (2001) Molecular epidemiology of an outbreak of Serratia Marcescens in a neonatal intensive care unit. Infect Control Hosp Epidemiol 22(10):630–634

    CAS  PubMed  Article  Google Scholar 

  46. 46.

    Gastmeier P (2014) Serratia Marcescens: an outbreak experience. Front Microbiol 5:81

    PubMed  PubMed Central  Article  Google Scholar 

  47. 47.

    Hejazi A, Falkiner FR (1997) Serratia marcescens. J Med Microbiol 46(11):903–912

    CAS  PubMed  Article  Google Scholar 

  48. 48.

    Virgincar N et al (2011) Klebsiella pneumoniae producing KPC carbapenemase in a district general hospital in the UK. J Hosp Infect 78(4):293–296

    CAS  PubMed  Article  Google Scholar 

  49. 49.

    Soulier A et al (1995) Decreased transmission of Enterobacteriaceae with extended-Spectrum Beta-lactamases in an intensive-care unit by nursing reorganization. J Hosp Infect 31(2):89–97

    CAS  PubMed  Article  Google Scholar 

  50. 50.

    Dancer SJ (2011) Hospital cleaning in the 21st century. Eur J Clin Microbiol Infect Dis 30(12):1473–1481

    CAS  PubMed  Article  Google Scholar 

  51. 51.

    Lucero CA et al (2011) Outbreak of Burkholderia cepacia complex among ventilated pediatric patients linked to hospital sinks. Am J Infect Control 39(9):775–778

    PubMed  Article  Google Scholar 

  52. 52.

    Dias MBS et al (2013) Multi-institutional outbreak of Burkholderia cepacia complex associated with contaminated mannitol solution prepared in compounding pharmacy. Am J Infect Control 41(11):1038–1042

    Article  Google Scholar 

  53. 53.

    Ko S et al (2015) An outbreak of Burkholderia cepacia complex pseudobacteremia associated with intrinsically contaminated commercial 0.5% chlorhexidine solution. Am J Infect Control 43(3):266–268

    CAS  PubMed  Article  Google Scholar 

  54. 54.

    Rutala WA, Weber DJ (1997) Uses of inorganic hypochlorite (bleach) in health-care facilities. Clin Microbiol Rev 10(4):597

    CAS  PubMed  PubMed Central  Google Scholar 

  55. 55.

    Morter S et al (2011) Norovirus in the hospital setting: virus introduction and spread within the hospital environment. J Hosp Infect 77(2):106–112

    CAS  PubMed  Article  Google Scholar 

  56. 56.

    MacCannell T et al (2011) Guideline for the prevention and control of norovirus gastroenteritis outbreaks in healthcare settings. Infect Control Hosp Epidemiol 32(10):939–969

    PubMed  Article  Google Scholar 

  57. 57.

    Liu PB et al (2010) Effectiveness of liquid soap and hand sanitizer against Norwalk virus on contaminated hands. Appl Environ Microbiol 76(2):394–399

    CAS  PubMed  Article  Google Scholar 

  58. 58.

    Barker J, Vipond IB, Bloomfield SF (2004) Effects of cleaning and disinfection in reducing the spread of norovirus contamination via environmental surfaces. J Hosp Infect 58(1):42–49

    CAS  PubMed  Article  Google Scholar 

  59. 59.

    Khan RM et al (2016) Middle East respiratory syndrome coronavirus on inanimate surfaces: a risk for health care transmission. Am J Infect Control 44(11):1387–1389

    PubMed  Article  Google Scholar 

  60. 60.

    van Doremalen N, Bushmaker T, Munster VJ (2013) Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions. Euro Surveill 18(38)

  61. 61.

    Warnes SL, Little ZR, Keevil CW (2015) Human coronavirus 229E remains infectious on common touch surface materials. MBio 6(6):e01697–e01615

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  62. 62.

    Schelenz S et al (2016) First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control 5

  63. 63.

    Carling PC et al (2008) Identifying opportunities to enhance environmental cleaning in 23 acute care hospitals. Infect Control Hosp Epidemiol 29(1):1–7

    CAS  PubMed  Article  Google Scholar 

  64. 64.

    Goodman ER et al (2008) Impact of an environmental cleaning intervention on the presence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on surfaces in intensive care unit rooms. Infect Control Hosp Epidemiol 29(7):593–599

    PubMed  PubMed Central  Article  Google Scholar 

  65. 65.

    Boyce JM (2016) Modern technologies for improving cleaning and disinfection of environmental surfaces in hospitals. Antimicrob Resist Infect Control 5

  66. 66.

    Anderson RE et al (2011) Cleanliness audit of clinical surfaces and equipment: who cleans what? J Hosp Infect 78(3):178–181

    CAS  PubMed  Article  Google Scholar 

  67. 67.

    Schabrun S, Chipchase L (2006) Healthcare equipment as a source of nosocomial infection: a systematic review. J Hosp Infect 63(3):239–245

    CAS  PubMed  Article  Google Scholar 

  68. 68.

    Dancer SJ (2014) Controlling hospital-acquired infection: focus on the role of the environment and new technologies for decontamination. Clin Microbiol Rev 27(4):665–690

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  69. 69.

    Rutala WA (1996) APIC guideline for selection and use of disinfectants. Am J Infect Control 24(4):313–342

    CAS  PubMed  Article  Google Scholar 

  70. 70.

    Sattar SA, Maillard JY (2013) The crucial role of wiping in decontamination of high-touch environmental surfaces: review of current status and directions for the future. Am J Infect Control 41(5):S97–S104

    PubMed  Article  Google Scholar 

  71. 71.

    Sattar SA (2010) Promises and pitfalls of recent advances in chemical means of preventing the spread of nosocomial infections by environmental surfaces. Am J Infect Control 38(5):S34–S40

    PubMed  Article  Google Scholar 

  72. 72.

    Russell AD (2004) Bacterial adaptation and resistance to antiseptics, disinfectants and preservatives is not a new phenomenon. J Hosp Infect 57(2):97–104

    CAS  PubMed  Article  Google Scholar 

  73. 73.

    Aldeyab MA et al (2009) Evaluation of the efficacy of a conventional cleaning regimen in removing methicillin-resistant Staphylococcus aureus from contaminated surfaces in an intensive care unit. Infect Control Hosp Epidemiol 30(3):304–306

    PubMed  Article  Google Scholar 

  74. 74.

    Rutala WA, Gergen MF, Weber DJ (2012) Efficacy of improved hydrogen peroxide against important healthcare-associated pathogens. Infect Control Hosp Epidemiol 33(11):1159–1161

    PubMed  Article  Google Scholar 

  75. 75.

    Boyce JM, Havill NL (2013) Evaluation of a new hydrogen peroxide wipe disinfectant. Infect Control Hosp Epidemiol 34(5):521–523

    PubMed  Article  Google Scholar 

  76. 76.

    Alfa MJ et al (2015) Use of a daily disinfectant cleaner instead of a daily cleaner reduced hospital-acquired infection rates. Am J Infect Control 43(2):141–146

    CAS  PubMed  Article  Google Scholar 

  77. 77.

    Rutala WA et al (2014) Effectiveness of improved hydrogen peroxide in decontaminating privacy curtains contaminated with multidrug-resistant pathogens. Am J Infect Control 42(4):426–428

    CAS  PubMed  Article  Google Scholar 

  78. 78.

    Carling PC et al (2014) Evaluating a new paradigm for comparing surface disinfection in clinical practice. Infect Control Hosp Epidemiol 35(11):1349–1355

    PubMed  Article  Google Scholar 

  79. 79.

    Meakin NS et al (2012) Comparison of cleaning efficacy between in-use disinfectant and electrolysed water in an English residential care home. J Hosp Infect 80(2):122–127

    CAS  PubMed  Article  Google Scholar 

  80. 80.

    Fertelli D et al (2013) Effectiveness of an electrochemically activated saline solution for disinfection of hospital equipment. Infect Control Hosp Epidemiol 34(5):543–544

    PubMed  Article  Google Scholar 

  81. 81.

    Cahill OJ et al (2014) Cold air plasma to decontaminate inanimate surfaces of the hospital environment. Appl Environ Microbiol 80(6):2004–2010

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  82. 82.

    O’connor N et al (2014) Cold atmospheric pressure plasma and decontamination. Can it contribute to preventing hospital-acquired infections? J Hosp Infect 88(2):59–65

    PubMed  Article  Google Scholar 

  83. 83.

    Unal N et al (2014) Evaluation of the efficacy of akacid plus (R) fogging in eradicating causative microorganism in nosocomial infections. Int J Clin Exp Med 7(12):5867–5871

    PubMed  PubMed Central  Google Scholar 

  84. 84.

    Rutala WA, Gergen MF, Weber DJ (2007) Microbiologic evaluation of microfiber mops for surface disinfection. Am J Infect Control 35(9):569–573

    PubMed  Article  Google Scholar 

  85. 85.

    Nerandzic MM et al (2010) Evaluation of an automated ultraviolet radiation device for decontamination of Clostridium difficile and other healthcare-associated pathogens in hospital rooms. Bmc Infect Dis 10

  86. 86.

    Memarzadeh F, Olmsted RN, Bartley JM (2010) Applications of ultraviolet germicidal irradiation disinfection in health care facilities: effective adjunct, but not stand-alone technology. Am J Infect Control 38(5):S13–S24

    PubMed  Article  Google Scholar 

  87. 87.

    Linley E et al (2012) Use of hydrogen peroxide as a biocide: new consideration of its mechanisms of biocidal action. J Antimicrob Chemother 67(7):1589–1596

    CAS  PubMed  Article  Google Scholar 

  88. 88.

    Mitchell BG et al (2014) Controlling methicillin-resistant Staphylococcus aureus (MRSA) in a hospital and the role of hydrogen peroxide decontamination: an interrupted time series analysis. Bmj Open 4(4)

  89. 89.

    Chmielarczyk A et al (2012) Control of an outbreak of Acinetobacter Baumannii infections using vaporized hydrogen peroxide. J Hosp Infect 81(4):239–245

    CAS  PubMed  Article  Google Scholar 

  90. 90.

    Falagas ME et al (2011) Airborne hydrogen peroxide for disinfection of the hospital environment and infection control: a systematic review. J Hosp Infect 78(3):171–177

    CAS  PubMed  Article  Google Scholar 

  91. 91.

    Bentley K et al (2012) Hydrogen peroxide vapour decontamination of surfaces artificially contaminated with norovirus surrogate feline calicivirus. J Hosp Infect 80(2):116–121

    CAS  PubMed  Article  Google Scholar 

  92. 92.

    Boyce JM et al (2008) Impact of hydrogen peroxide vapor room decontamination on Clostridium Difficile environmental contamination and transmission in a healthcare setting. Infect Control Hosp Epidemiol 29(8):723–729

    PubMed  Article  Google Scholar 

  93. 93.

    Hall L et al (2008) Deactivation of the dimorphic fungi Histoplasma capsulatum, Blastomyces dermatitidis and Coccidioides immitis using hydrogen peroxide vapor. Med Mycol 46(2):189–191

    CAS  PubMed  Article  Google Scholar 

  94. 94.

    Dancer SJ (2013) Floor wars: the battle for ‘clean’ surfaces. J Hosp Infect 84(4):339–340

    CAS  PubMed  Article  Google Scholar 

  95. 95.

    Jeanes A et al (2005) Eradication of persistent environmental MRSA. J Hosp Infect 61(1):85–86

    CAS  PubMed  Article  Google Scholar 

  96. 96.

    Dryden M et al (2008) Hydrogen peroxide vapour decontamination in the control of a polyclonal meticillin-resistant Staphylococcus aureus outbreak on a surgical ward. J Hosp Infect 68(2):190–192

    CAS  PubMed  Article  Google Scholar 

  97. 97.

    Otter JA et al (2010) Hydrogen peroxide vapor decontamination of an intensive care unit to remove environmental reservoirs of multidrug-resistant gram-negative rods during an outbreak. Am J Infect Control 38(9):754–756

    PubMed  Article  Google Scholar 

  98. 98.

    Cooper T et al (2011) Impact of environmental decontamination using hydrogen peroxide vapour on the incidence of Clostridium difficile infection in one hospital trust. J Hosp Infect 78(3):238–240

    CAS  PubMed  Article  Google Scholar 

  99. 99.

    Ray A et al (2010) Use of vaporized hydrogen peroxide decontamination during an outbreak of multidrug-resistant Acinetobacter Baumannii infection at a long-term acute care hospital. Infect Control Hosp Epidemiol 31(12):1236–1241

    PubMed  PubMed Central  Article  Google Scholar 

  100. 100.

    Martin NL, Bass P, Liss SN (2015) Antibacterial properties and mechanism of activity of a novel silver-stabilized hydrogen peroxide. Plos One 10(7)

  101. 101.

    Silva AP et al (2010) Efficacy of hydrogen peroxide dry-mist disinfection system for hospital environment disinfection. J Hosp Infect 76(Suppl 1):S23

  102. 102.

    Sexton JD et al (2011) Reduction in the microbial load on high-touch surfaces in hospital rooms by treatment with a portable saturated steam vapor disinfection system. Am J Infect Control 39(8):655–662

    PubMed  Article  Google Scholar 

  103. 103.

    Tanner BD (2009) Reduction in infection risk through treatment of microbially contaminated surfaces with a novel, portable, saturated steam vapor disinfection system. Am J Infect Control 37(1):20–27

    PubMed  Article  Google Scholar 

  104. 104.

    Griffith CJ, Dancer SJ (2009) Hospital cleaning: problems with steam cleaning and microfibre. J Hosp Infect 72(4):360–361

    CAS  PubMed  Article  Google Scholar 

  105. 105.

    Sharma M, Hudson JB (2008) Ozone gas is an effective and practical antibacterial agent. Am J Infect Control 36(8):559–563

    PubMed  Article  Google Scholar 

  106. 106.

    Cardoso CC et al (2000) Disinfection of hospital laundry using ozone: microbiological evaluation. Infect Control Hosp Epidemiol 21(4):248–248

    CAS  PubMed  Article  Google Scholar 

  107. 107.

    de Boer HEL et al (2006) Use of gaseous ozone for eradication of methicillin-resistant Staphylococcus aureus from the home environment of a colonized hospital employee. Infect Control Hosp Epidemiol 27(10):1120–1122

    PubMed  Article  Google Scholar 

  108. 108.

    Davies A et al (2011) Gaseous and air decontamination technologies for Clostridium difficile in the healthcare environment. J Hosp Infect 77(3):199–203

    CAS  PubMed  Article  Google Scholar 

  109. 109.

    Hamblin MR et al (2005) Helicobacter pylori accumulates photoactive porphyrins and is killed by visible light. Antimicrob Agents Chemother 49(7):2822–2827

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  110. 110.

    Maclean M et al (2010) Environmental decontamination of a hospital isolation room using high-intensity narrow-spectrum light. J Hosp Infect 76(3):247–251

    CAS  PubMed  Article  Google Scholar 

  111. 111.

    Maclean M et al (2008) High-intensity narrow-spectrum light inactivation and wavelength sensitivity of Staphylococcus aureus. FEMS Microbiol Lett 285(2):227–232

    CAS  PubMed  Article  Google Scholar 

  112. 112.

    Maclean M et al (2009) Inactivation of bacterial pathogens following exposure to light from a 405-nanometer light-emitting diode Array. Appl Environ Microbiol 75(7):1932–1937

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  113. 113.

    Bache SE et al (2012) Clinical studies of the high-intensity narrow-Spectrum light environmental decontamination system (HINS-light EDS), for continuous disinfection in the burn unit inpatient and outpatient settings. Burns 38(1):69–76

    PubMed  Article  Google Scholar 

  114. 114.

    Parkin IP, Palgrave RG (2005) Self-cleaning coatings. J Mater Chem 15(17):1689–1695

    CAS  Article  Google Scholar 

  115. 115.

    Park KD et al (1998) Bacterial adhesion on PEG modified polyurethane surfaces. Biomaterials 19(7–9):851–859

    CAS  PubMed  Article  Google Scholar 

  116. 116.

    Hauert R (2003) A review of modified DLC coatings for biological applications. Diam Relat Mater 12(3–7):583–589

    CAS  Article  Google Scholar 

  117. 117.

    Weber DJ, Rutala WA (2013) Self-disinfecting surfaces: review of current methodologies and future prospects. Am J Infect Control 41(5 Suppl):S31–S35

    PubMed  Article  Google Scholar 

  118. 118.

    Lansdown AB (2006) Silver in health care: antimicrobial effects and safety in use. Curr Probl Dermatol 33:17–34

    CAS  PubMed  Article  Google Scholar 

  119. 119.

    Stobie N et al (2010) Dual-action hygienic coatings: benefits of hydrophobicity and silver ion release for protection of environmental and clinical surfaces. J Colloid Interface Sci 345(2):286–292

    CAS  PubMed  Article  Google Scholar 

  120. 120.

    Salgado CD et al (2013) Copper surfaces reduce the rate of healthcare-acquired infections in the intensive care unit. Infect Control Hosp Epidemiol 34(5):479–486

    PubMed  Article  Google Scholar 

  121. 121.

    Casey AL et al (2010) Role of copper in reducing hospital environment contamination. J Hosp Infect 74(1):72–77

    CAS  PubMed  Article  Google Scholar 

  122. 122.

    Klibanov AM (2007) Permanently microbicidal materials coatings. J Mater Chem 17(24):2479–2482

    CAS  Article  Google Scholar 

  123. 123.

    Petersen RC (2016) Triclosan antimicrobial polymers. Aims Mol Sci 3(1):88–103

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  124. 124.

    Chen LK et al (2013) Potential of bacteriophage phi AB2 as an environmental biocontrol agent for the control of multidrug-resistant Acinetobacter baumannii. Bmc Microbiol 13

  125. 125.

    Page K, Wilson M, Parkin IP (2009) Antimicrobial surfaces and their potential in reducing the role of the inanimate environment in the incidence of hospital-acquired infections. J Mater Chem 19(23):3819–3831

    CAS  Article  Google Scholar 

  126. 126.

    Bogdan J, Zarzynska J, Plawinska-Czarnak J (2015) Comparison of infectious agents susceptibility to photocatalytic effects of nanosized titanium and zinc oxides: a practical approach. Nanosc Res Lett 10

  127. 127.

    Wilson M (2003) Light-activated antimicrobial coating for the continuous disinfection of surfaces. Infect Control Hosp Epidemiol 24(10):782–784

    PubMed  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to L. Cobrado.

Ethics declarations


None to declare.

Conflict of interest

None to declare.

Ethical approval

This type of study does not involve human participants and/or animals.

Informed consent

For this type of study, informed consent is not required.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Cobrado, L., Silva-Dias, A., Azevedo, M.M. et al. High-touch surfaces: microbial neighbours at hand. Eur J Clin Microbiol Infect Dis 36, 2053–2062 (2017).

Download citation


  • High-touch Surfaces (HTS)
  • Healthcare-associated Infections (HAIs)
  • Patient Care Items
  • Antimicrobial Surfaces
  • Surface Environment